Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ET-700 versus Galzin versus placebo in healthy adults using 64Cu PET/CT
2025-523372-24-00Phase 2Completed
- Sponsor
- Central Denmark Region
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of zinc acetate in Wilson disease (WD) (3 arms), sponsored by Central Denmark Region. Primary endpoint: Change in mean hepatic 64Cu standard uptake value. Started Mar 2026; status: completed.
02
Drugs
zinc acetate
03
Conditions
Wilson disease (WD)
Beyond the preview
Go deeper on 2025-523372-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523372-24-00.